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Abstract
Fibromyalgia Syndrome (FM) has been defined as a "specific, chronic,
non-degenerative, non-progressive, non-inflammatory, systemic pain condition."
It is a syndrome, not a disease, since it is characterized by a specific set of signs
and symptoms that occur together. It is currently estimated that seven to ten
million Americans are affected by this syndrome. Because FM has few
symptoms that are outwardly visible and almost every part of the body can be
affected, it has been termed "the invisible disability" or the "irritable everything"
syndrome.
Because of the growing number of diagnosises being made and the wide
spread physical abnormalities observed, FM has been studied extensively.
Despite these many studies, no cause has been identified. However, these
studies have provided insight into the complexity of this syndrome. There is now
evidence for neuroendocrine abnormalities in Fibromyalgia patients as a result of
the continued stress they encounter. These abnormalities seem to center around
a dysfunction of negative feedback mechanisms within the hypothalamicpituitary-adrenal axis. Furthermore, it seems as though there may be a link
between the high levels of stress and pain experienced by these patients.
It is now being assumed that the solution to this syndrome may exist not in
one single dysfunction, but rather in several abnormalities that feed off of each
other to result in the symptoms of fibromyalgia. By examining these
relationships, a clearer perspective may be obtained of the elusive cause of FM.
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Introduction
As diagnosises for Fibromyalgia (FM) continue to increase at a drastic
rate, researchers have responded accordingly with over 1000 articles appearing
in the last decade. The two most prominent areas of study attempting to explain
this syndrome's origin have surrounded the issues of stress and pain. In this
work, FM and the stress response system will be reviewed, and the existing
research linking this response to FM will be presented and discussed. As the
current research is presented, abnormalities in the neuroendocrine response to
stress will become apparent. In addition to this, an attempt will be made to
demonstrate the relationship between neuroendocrine abnormalities and
persistent pain in fibromyalgia patients. Finally, a possible genetic predisposition
for such abnormalities and ideas for future research on this syndrome will be
explored.

Fibromyalgia
Fibromyalgia Syndrome, while first described by physicians in 1816, was
not officially recognized by the American Medical Association as a true illness
until 1987. It has been defined as a specific, chronic, non-degenerative, nonprogressive, non-inflammatory, systemic pain condition (1). Unlike a disease,
which has known causes and understood mechanisms for producing symptoms,
FM, which is of unknown etiology, has been characterized as a syndrome, or
having a specific set of signs and symptoms that occur together.
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Epidemiology
It is estimated that anywhere from 3 to 10 million people are affected by
FM, and it is the third most commonly diagnosed rheumatic disorder after
osteoarthritis and rheumatoid arthritis (2, 3). It is seen in all races and age
groups with the median onset of the syndrome occurring from 29 to 37 years (3).
Unfortunately the median age of formal diagnosis for FM is 34 to 53 years,
meaning that most patients endure symptoms for many years before they receive
an accurate diagnosis (2). This usually occurs because fibromyalgia is frequently
misdiagnosed and often confused with other disorders such as myofascial pain
syndrome, hypothyroidism, rheumatoid arthritis, and chronic fatigue syndrome
(2). While this syndrome does not seem to be age specific, it does target by
gender. Fibromyalgia affects women much more than men in an approximate
ratio of 20:1 (3). In addition to this, 90% of the patients treated in rheumatology
practices for fibromyalgia are women (2).

Symptoms
Because FM has few symptoms that are outwardly visible, it has been
nicknamed "the invisible disability" or the "irritable everything" syndrome (4). The
most common characteristic of fibromyalgia is that of pain. The pain of FM is
profound, widespread and chronic. It knows no boundaries, migrating to all parts
of the body and varying in intensity. It has been described as a deep muscular
aching, throbbing, stabbing and shooting pain that defines the very existence of
the fibromyalgia patient (3). While this extreme pain is a reality for many FM
patients, others report a much lower pain intensity that is only a moderate in
nature. Fatigue is a symptom that is also highly reported as problematic in 78 to
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94% of FM patients (5). Interestingly, fatigue seems to be more prevalent in FM
than in other rheumatological conditions. Furthermore, in a study examining
daily fatigue and pain in FM, fatigue was reported to constitute a greater obstacle
in the accomplishment of daily tasks than pain (5).
In addition to pain and fatigue, a number of other symptoms are usually
reported and associated with FM. Many patients also complain of sleep
disturbances. Despite sufficient amounts of sleep, patients may awaken feeling
unrefreshed as well as having difficulty falling asleep or staying asleep (4).
Another major symptomatic problem of Fibromyalgia seems to be depression.
Although reports are somewhat unclear on the true numbers affected by
depression with estimates ranging from 14-76% (5). Typically patients also
suffer from one or more of the following: body stiffness, increased headaches or
facial pain, cognitive disorders including spaciness or memory lapses,
paresthesia (numbness and tingling particularly in the hands and feet),
myofascial trigger points, chest pain, dysequilibrium, restless leg syndrome (an
irresistible urge to move the legs particularly when at rest), irritable bowel
syndrome (includes abdominal pain, bloating, constipation and/or diarrhea),
increased frequency of urination, hypersensitivity to light, sound, touch, and
odors, and skin complaints such as itchy, dry, or blotchy skin (2,4).

Diagnosis
Despite these numerous symptoms, a physician's diagnosis of FM is
based on taking a careful history and finding tender pOints in specific areas of
muscle (3). In 1990, the American College of Rheumatology concluded that
fibromyalgia could be diagnosed by two specific criteria: a history of widespread
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pain occurring for longer than 3 months in all four quadrants of the body, and
identified pain in 11 or more of 18 specified bilateral tender points in muscular
tissue (Figure 1) when approximately four kilograms of pressure was applied

(2,3,4,6).

Figure 1: Fibromyalgia Tender Points Identified By
The American College of Rheumatology in 1990 (4)

Tender points can occur in muscles, ligaments, or tendons and localize pain
upon stimulation rather than referring it to an adjacent area as a trigger +point
would (2). The presence of these many tender points has been correlated with
depression, fatigue, anxiety, and other somatic symptoms as well as with pain
(6). These set requirements for a diagnosis of FM provided a sensitivity of 88%
and a specificity of 81 % in distinguishing FM from other causes of chronic
musculoskeletal pain (6).
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Endocrinology
Throughout this work, some specific aspects of the endocrine and
neuroendocrine system will be examined. The body can be affected either
directly or indirectly by external changes and can only survive if the consistency
of its environment can be controlled. The endocrine system is one way in which
the body responds to reoccurring environmental changes. The word "endocrine"
refers to the internal secretion of biologically active substances, which are
commonly known as hormones. Hormones are released by endocrine glands
and transported through the bloodstream to designated tissues. Once there,
they act by binding to specific receptors on a target cell's surface or within the
cell, which generally results in a cascade of intracellular reactions and therefore
amplifies the original stimulus (7).
Traditionally the endocrine system is distinguished from the nervous
system because the nervous system is connected to its target tissues through
neurons that carry and transmit chemical signals (8). This is accomplished
through neurotransmitters that mediate the synaptic transmission between two
neurons. These chemical transmitters are synthesized in the cell body and travel
down an axon where they are stored in synaptic vesicles and released upon
depolarization. Unlike hormones, neurotransmitters act directly in the target's
vicinity instead of traveling through the circulatory system and being distributed to
all tissues. This allows the release of high concentrations of a transmitter to a
particular target while preventing the release of that transmitter at other locations
throughout the body (8). It is interesting to note that the same molecule may act
either as a hormone or as a neurotransmitter depending on where it is being
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released within the body (8). Sometimes both neurotransmitters and hormones
are secreted by neurons, forming an interaction which is known as the
neuroendocrine system (7). Both of these systems help maintain the body's
internal environment and can cause important long-term changes in an
organism's behavior that mayor may not be beneficial.

Physiology of the Stress Response
General Response to Stress
As previously mentioned, the body is in a constant struggle to combat
external changes and maintain homeostasis, or a dynamic steady state. Any
adverse force that causes a series of reactions that alters the body's
homeostasis is known as a stressor. When faced with excessive demands, a
person's adaptive responses take on a stereotypic nature, a state known as
"stress." More specifically, stress can be defined as a state in which the brain
interprets the quantity of stimulation to be excessive or the quality of stimulation
threatening with the brain subsequently responding in a generalized manner (10,
11). A good understanding of the systems that control the response to stress
and their physiological consequences is necessary when examining the negative
impact of stress.
During stress, attention is enhanced, and the brain focuses on the
perceived stress. Cardiac output and respiration are enhanced, and blood flow is
redirected to fuel the aroused brain, heart, and muscles. Furthermore, normal
endocrine functions such as growth, reproduction, and pleasure are shut down to
conserve needed energy (11).
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The stress response, which is initiated by both the nervous and endocrine
systems, is centrally controlled through systems located in the hypothalamus and
brain stem (9, 12). These control systems include corticotropin-releasing
hormone (CRH), arginine-vasopressin (AVP) neurons of the hypothalamus, and
the locus ceruleus-norepinephrine (LC/NE) system (the central sympathetic
system) (12). The hypothalamic-pituitary-adrenal (HPA) axis and the
sympathetic system represent the effector limbs by which the brain influences all
organs in the body throughout the duration of stressful stimuli (11, 12). In
addition to this, there are interactions of these stress systems with three higher
brain control areas that influence anticipatory response (mesocortical/mesolimbic
systems); the initiation, propagation, and termination of stress system activity
(amygdala/hippocampus); and the setting of pain sensation (arcuate nucleus)
(12).
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Figure 2: Hypothalamic-pituitary-adrenal axis (13)
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The HPA axis
The HPA axis (Figure 2) is an example of a negative feedback system and
mainly involves the synthesis and release of three hormones: adrenocorticotropic
hormone (ACTH), corticotropin releasing hormone (CRH), and cortisol (10). The
hypothalamus controls the secretion of ACTH from the anterior pituitary, which
then stimulates the adrenal cortex to release glucocorticoid hormones (11, 12).
The main glucocorticoid hormone secreted in humans is cortisol (11). An
excessive amount of this hormone has long been known to mark subjects
undergoing stress. After intensive research, the factor responsible for
corticotropin secretion was isolated as a 41 amino acid peptide and named CRH
(10-12).
After its release, CRH acts as the main hypothalamic mediator of HPA
axis activation by regulating ACTH secretion (11, 13). Arginine vasopressin
(AVP) has little ability to stimulate ACTH secretion on its own, but when
combined with CRH, the two work synergistically to increase ACTH secretion
(11-13). CRH and AVP control ACTH production and release through separate
receptors and signaling pathways, allowing for a very rapid increase in ACTH
secretion when circulating glucocorticoid levels become too low (10). This is
made possible through reciprocal positive interaction where each neuropeptide is
capable of stimulating the other (11).
Under nonstressful conditions, both CRH and AVP are secreted in a
circadian (24 hour), pulsing fashion, with about two to three secretatory pulses
per hour (12). Under resting conditions, the amplitude of these pulses increases
in the early morning, which results in ACTH and cortisol bursts in the general
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circulation (12). These are known as diurnal variations and can be disrupted by
stress (11). During stress, the amplitude and frequency of CRH and AVP pulses
increase, therefore resulting in a marked increase of ACTH and cortisol
secretatory bursts (11, 12).
Glucocorticoids are the final products of the HPA axis and are involved in
maintaining whole body homeostasis and the response to stress. They assist in
regulating the basal level of the HPA axis as well as the termination of the stress
response (12). Through inhibitory negative feedback on ACTH secretion, the
time that tissues are exposed to glucocorticoids is limited (12). This minimizes
their catabolic, immunosuppressive, and anti-inflammatory effects, which limits
the possibility of tissue destruction (14).

Chronic Stress
Chronic stress can alter the body's normal response in a different manner
than acute stress (15). The stress response is intended to be limited in duration
with an appropriate initiation, amplitude, and termination (11). This limited nature
of the response renders the effects beneficial rather than damaging (12). In
contrast, chronic activation of the stress system can lead to a syndromal state
described by Selye in 1936 (12).

Chronic HyperlHypoactivation of the Stress System
Because CRH is involved in almost every area of stress adaptation, the
magnitude and duration of its production has been evaluated to help explain the
pathogenesis of many syndromes (12). The best example of chronic
hyperactivation is seen in melancholic depression. Here cortisol secretion is
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increased, and ACTH response to CRH is decreased (11, 12). Another strong
example of an overactive axis is demonstrated in Cushing's disease. This
disease is characterized by a feedback abnormality, where CRH and ACTH
secretion are only suppressed at inappropriately high circulating levels of cortisol,
resulting in hypercortisolaemia (7,8). Chronic hypoarousal, however, is
characterized by chronically reduced secretion of CRH (12). This state has been
consistently linked with atypical depression and chronic fatigue syndrome (11,
12). In this glucocorticoid-deficient state it is believed that the body remains
relatively resistant to infections but has an increased susceptibility to
autoimmune/inflammatory diseases (11, 12). While the above descriptions
involving CRH levels are accurate, a more simplistic understanding of these two
states is possible. In order to maintain sensitivity to new incoming stressors
during chronic stress the body has two options: to increase the drive on
hormone production and release resulting in a hyperfunctioning axis, or to
become resistant to the effect of circulating glucocorticoids which would result in
a hypofunctioning axis (14). In either case, the appropriate negative feedback
within the HPA axis is lost (14).

Fibromyalgia and Stress
It has been frequently observed that the onset of FM symptoms occurs
following a significant stress or period of stress, such as a death in the family or a
serious illness (13). In addition to this, approximately 65% of patients report that
the intensity of their symptoms directly correlates with their current stress level
(16, 22). It is also important to remember that simply living with a syndrome such
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as FM results in exposure to a chronic stressor. The reported rates of
depression previously mentioned far exceed the rates in normal healthy
populations, indicating a high degree of emotional distress as well (22). With this
information, much of the research over the past decade has concentrated on
examining the stress response system in fibromyalgia patients. Although some
of the data and interpretations accumulated by researchers are conflicting, all
agree that there are abnormalities in the FM patient's neuroendocrine response
to stress. It is because of this that some researchers have started to consider
FM as a "stress-related syndrome" (14-18).

Research Data
Studies performed by McCain and Tilbe on basal HPA axis function in
patients with FM demonstrated low 24-hour urine free cortisol levels compared
with normal subjects (13, 16-19, 21, 24, 25). Patients also showed normal
morning (peak) and elevated evening (trough) cortisol levels, resulting in the loss
of normal diurnal cortisol fluctuation. In this flattened diurnal cortisol pattern, the
elevated cortisol levels could not be suppressed by dexamethasone, a potent
glucocorticoid that normally suppresses pituitary ACTH and results in a decrease
of plasma and urine corticosteroids (13,16-19,21,24,25). Furthermore,
abnormal cortisol levels seem to predominate in patients who have suffered from
FM for a duration greater than two years (13, 16). All of these results were
confirmed in a later more expanded study by Ferraccioli et al. It should be noted
however, that in one study by Adler et al. 24-hour urinary free cortisol, and the
diurnal pattern were reported as normal (23).
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In order to determine whether or not this abnormality originated at the
hypothalamic or pituitary level, Griep et al. injected patients with CRH in the
morning, when no significant difference in cortisol levels should exist. This test of

the HPA axis's response to injected CRH is a fairly accurate measurement of its
stress-induced activation. Results revealed a hyperactive ACTH release with a
blunted cortisol response relative to the ACTH stimulation (18, 19,24,25). In a
similar study by Riedel et aI., basal values of ACTH and cortisol were shown to
be higher prior to the CRH stimulation (19). A more recent study by Griep et al.
comparing FM patients, patients with low back pain, and controls concluded that
while pre-stimulation basal levels of ACTH appeared higher, the basal cortisol
levels were significantly reduced (21). Despite the pre-stimulation discrepanCies,
both of the previously mentioned studies confirmed that following CRH injection
only ACTH reached a higher level in FM patients, while no significant changes in
cortisol concentrations were observed (19, 21).

In addition to this, the latter

study reported that not only was the ACTH response hyperactive in magnitude, it
was also significantly more prolonged (21). The results of the Griep et al. study
can be seen in Figure 3. Similar results to the previous studies were also
confirmed in experimental data by Crofford (13, 16). Furthermore, Crofford
observed low cortisol levels following exercise and an increase release of AVP,
with five of the twelve patients achieving AVP levels more than two standard
deviations above the highest control value (13, 16).
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Figure 3: Response of ACTH and cortisol to patients with FM (closed circle),
with low back pain (closed square), and healthy controls (open circle); arrow
indicates the time of injection (20).

Discussion of Data
The results demonstrating low 24-hour urine free cortisol, which reflects
the time-integrated plasma free cortisol concentrations over 24 hours, seem
incongruent with the corresponding occurrence of higher cortisol levels in the
evening but normal morning levels. A plausible explanation provided by Crofford
hinges on the pulsing nature of cortisol secretion. There are normally eight to
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nine peaks of cortisol over a 24-hour period, with the highest secretion occurring
during the nighttime (8). These theoretically should be in response to basal
surges of CRH and ACTH. It is possible that in FM, the height of the cortisol
peaks might be normal or elevated, but the frequency of the peaks could be
decreased, resulting in a low cortisol output over a 24 hour period (13, 16, 18,
24).
The results of the experiments involving CRH become much more difficult
to explain. Although many researchers found similar data, there have been
several different interpretations concerning the implications of those results.
Earlier studies by Crofford et al. explain the blunted cortisol response to ACTH
release as the result of a hyporesponsive adrenal gland due to hypoactivity of the
adrenal cortex or through chronic understimulation from deficiencies of CRH or
ACTH (13,16). This interpretation has been linked to similar findings in patients
with CFS, as both syndromes are permeated by fatigue (13). Interestingly, in
Crofford's latest published work the conclusion made from the same data is
characterized by a hyperactivity of the stress system, instead of the previously
mentioned hypo responsive system. In this work Crofford correlates the results to
comparable findings in patients with depression or Cushing's syndrome (18).
Similarly, Neeck interprets the data as a hyperfunctioning system resulting as an
adaptive mechanism of a chronically stimulated adrenal cortex with a decrease in
receptor regulation (19). In Griep's most recent study he explains the results as
the apparent hyporesponsiveness of cortisol secretion to increased ACTH
stimulation, which is known as hypocortisolemia (21). This is in direct conflict
with Crofford's correlation of FM to Cushing's syndrome, which is characterized
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by hypercortisolaemia (8). In addition to this Griep also states that the HPA
activity in FM is clearly different from that of depression, which is characterized
by a hyperactivity of all parts of the HPA axis (21). He argues that in depression
the feedback abnormality is found at the corticosteroid level, while it is more
probable that in FM the feedback resistance exists at the glucocorticoid level
(21). This conclusion is based on his findings that the ACTH response to CRH is
more prolonged, suggesting a defect in cortisol control. This impaired feedback
may be a result of glucocorticoid receptor function, instead of the adrenal
receptor function suggested by Neeck (21).

The Link Between Stress and Pain
Two of the major systems affected by fibromyalgia are the stressregulating system and the nociceptive system. While the stress response has
been extensively reviewed thus far, the primary complaint of these patients is still
pain related. There are generally two types of pain described by FM patients:
Allodynia, pain from normally non-painful stimuli and Hyperalgesia, an increase
in pain intensity and prolonged pain duration from normally painful stimuli (27).
In accordance with this, studies have shown that pain thresholds in these
patients are two to three times lower than the levels in healthy controls (25).
Recently many researchers have concluded that the origin of fibromyalgia
exists within abnormal processing of the Central Nervous System (20, 25, 27,
28). Proponents of this theory believe that the long-standing excitation of
nociceptors may initiate and maintain a constant hyper-excitability in pain
response (27). These same researchers believe that abnormalities seen in the
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stress response system result only from chronic pain. It is believed that since
pain is both a chronic and emotional stressor, it exists as the sole trigger of
hormonal abnormalities. At the same time, there are those that still believe that
the primary cause of FM symptoms is a result of other stressors, which in turn
trigger abnormal pain behavior to perpetuate the cycle (13, 16, 17).

General Interactions
Regardless of whether or not stress or pain is the initial activating factor,
these two systems are intertwined through a myriad of various feedback loops.
Their interaction exists on such a level in which the alteration of one system will
inevitably have some effect on the components of the other. This is
demonstrated by the fact that a temporary increase in pain and allodynia is
almost always correlated to an increase in the patient's stress level (27).
Additionally, patients who score higher on all pain scales also score higher on
tests for anxiety, depression, and general distress (28). It is also interesting to
note that some of the most successful treatments of pain involve a reduction in
stress. Patients who are most successful in lowering their pain levels have at
least one of three characteristics in common: a high level of self-efficacy (the
belief in one's ability to engage in actions sufficient to attain a desired health
outcome), a belief that they personally posses the ability to control and decrease
their pain, and a frequent use of adaptive coping strategies and support groups
(25). Each of these characteristics demonstrates an obvious and direct reduction
in personal stress.
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Specific Interactions
It has been proposed that CRH may be the crucial link between the pain
and stress responses. CRH activity may determine not only the symptoms of
FM, but may also be the cause of many hormonal deviations previously
discussed. Since altered levels of CRH have been observed in situations that
are initiated and driven by either pain or stress, it is possible that this hormone
plays a role in resetting endocrine and nociceptive mechanisms (20).

The influence of pain response on the stress system
The pain response system has a direct effect on the HPA axis by
changing CRH levels. The change in CRH levels has been linked to two specific
factors: Neuropeptide Y (NPY) and Serotonin (5-HT) (16, 19, 20). NPY colocalizes with norepinephrine and its levels represent sympathetic adrenal output
(13). In FM patients, plasma NPY levels are much lower than controls (16). This
is significant since the presence of NPY has been reported to increase
concentrations of CRH (16). 5-HT plays an important role in the pain response
system since one of its functions is to block the brain's perception of painful
stimuli. Studies have found significantly lower serum levels of 5-HT in FM
patients (19, 20). As would be expected, a highly inverse relationship was found
between 5-HT levels and the intensity of perceived musculoskeletal pain (20). It
is possible that low 5-HT levels may decrease anti nociceptive mechanisms within
the spinal cord, explaining allodynia in FM patients. In addition to this, 5-HT is
linked to the regulation of the HPA axis through CRH. CRH containing neurons
receive synaptic input from 5-HT neurons, which is one of the mechanisms by
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which CRH is released (19). Here an abnormality in pain processing influences
the stress response system to also respond in an irregular manner.

The influence of stress response on pain perception
In other mechanisms, altered levels of CRH may result in increased pain
perception. As chronic stress persists, there seems to be a loss of negative
feedback as previously discussed. As CRH levels increase, the release of
somatostatin occurs, which serves to inhibit the release of growth hormone (GH)
and insulin-like growth factor (IGF-I) (19). Studies have shown that both GH and
IGF-I have low 24-hour levels in FM patients (14). Some have speculated that
impaired GH secretion may disturb normal muscle homeostasis and therefore
induce muscular pain (20). Additionally, it has been shown that decreased levels
of IGF-I are associated with lower pain thresholds. In a study on rats,
administration of IGF-I resulted in an increase in nociceptive threshold, and
chronic administration resulted in a halted progression of hyperalgesia (14).
As levels of CRH rise there tends to be a blunted response of
glucocorticoids in FM patients as previously discussed. Since glucocorticoids
serve as powerful anti-inflammatory agents, a decreased response should
theoretically result in increased inflammation. Interestingly, pain researchers
have found that hyperalgesia can result from increased inflammation with a result
almost identical to persistent pain conditions (25). Following inflammation,
nociceptive neurons often have an increased excitability and an increased
response to mechanical, thermal, and chemical stimuli. This hyperexcitability
leads to increased activity at higher brain centers and is perceived as more
intense and prolonged pain as seen in Figure 4 (14, 25). This possible
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mechanism could serve to explain both the allodynia and hyperalgesia exhibited
by fibromyalgia patients.
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Figure 4: (a) Under normal conditions, low frequency activation of nociceptors
by mild noxious stimuli results in an appropriate pain response. Activation of
non-noxious mechanoreceptors also results in a response but at a level
insufficient to initiate a pain response. (b) Following increased inflammation, the
same noxious stimulus is correlated with persistent noxious input to the brain.
There is also recruitment of the previously silent synapse and the activation of
the mechanoreceptors is now sufficient to result in a pain response (14).

A Predisposition for Fibromyalgia
Due to the nature of this syndrome and the possible neuroendocrine
involvement in its pathogenesis, it seems highly probable that fibromyalgia
patients have some sort of vulnerability to the onset and continuation of
symptoms. Additional support for this idea exists, as FM has been shown to
have a high occurrence in more than one member of a family (27). Genetic and
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environmental factors work together throughout development to shape the
specific phenotype of an individual. Therefore the HPA axis is variable among
individuals and can be determined by a number of different factors (13).
The importance of genetic variability has been demonstrated in studies of
various rat strains. For example, Lewis rats have been shown to have a blunted
HPA axis response when exposed to a variety of stressors, while Fischer rats
display an exaggerated HPA axis response when exposed to the same stressors
(17,22). Lewis rats also show differences in levels of CRH and AVP peptide
hormones as well as receptors for serotonin (26). In addition to this, these
various strains also demonstrate differences in diseased susceptibility, vigilance,
exploration, and apparent fear, which may all be related to differences in the
central components of the HPA axis (17).
In another study, the importance of neonatal environmental factors was
observed. Here male Long Evans rats were exposed to either repeated pain or
maternal separation in the first two weeks of life (25). After exposure, the rats
demonstrated enhanced central neurocircuit activity and HPA axis
responsiveness as well as extreme anxiety and a reactivity of the dopaminergic
system (24, 25). These alterations were perpetuated into adulthood where HPA
axis function, central gene expression, and pain threshold abnormalities were
exhibited (25). This study suggests that adverse early experiences, such as
neglect or abuse, can significantly modify the body's response to major stressors
encountered later in life.
These studies give some insight into a possible origin of fibromyalgia,
which otherwise seems to have an unexplainable onset. It is therefore possible
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that genetics and experience may contribute to a vulnerability of stress-related
syndromes that have classic physical and psychological symptomology.
However, the specific mechanisms by which a proceeding acute stress is

translated into a syndrome of chronic pain still remain to be determined.

Future Research and Conclusion
Despite the various interpretations of data previously stated, it is obvious
that neuroendocrine abnormalities do exist throughout the HPA axis. Whether
the result is of a hyper or a hypo functioning stress response, there is agreement
that negative feedback systems are impaired. More progress may be made
when researchers cease trying to categorize FM under broad categories like the
hyper/hypo functioning HPA axis, therefore linking it to other disorders. It seems
clear that FM is not identical to any other syndrome or illness and therefore
should not be similarly categorized. By viewing this syndrome as its own distinct
entity, more options may present themselves concerning the syndrome's
etiology.
Those who have started to view FM as a disorder of pain processing in the
Central Nervous System have been able to examine the syndrome without
consistently linking it to other disorders. However, much of the research in this
field blatantly ignores pertinent research on stress induced neuroendocrine
abnormalities. In 1997 a small conference workshop was held inviting experts in
the fields of pain and neuroendocrine function in FM patients. After sharing their
acquired knowledge, a combined work was written concluding that the integration
of neuroendocrine and pain research was imperative to the future research and
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understanding of FM (24). Unfortunately, to this date no such work can be found
linking these two most pursued research fields. It is highly probable that the
etiology of the syndrome will not be discovered until an interdisciplinary approach
is taken, and the interactions of these systems are fully examined.
Specifically, more research is needed on the psychosocial factors involved
in pain vulnerability and expression, which may demonstrate a genetic
predisposition to chronic pain conditions. This possibility could help prove the
theory that the syndrome originates as a pain disorder, which is perpetuated by
the stress of pain. Similarly, those supporting the stress origin need to
investigate a way to distinguish neuroendocrine vulnerability leading to the
development of FM from abnormalities that might result from the syndrome.
Since many studies are done on patients who have been ill for several years, it is
difficult to know whether or not the observed abnormalities in the HPA axis
represent a pre-existing, intrinsic defect, or if the abnormalities are acquired as a
result of FM symptoms.
Finally, in FM research there seems to be a pervasiveness of inconsistent
findings. A possible explanation and direction for future research has been
proposed involving the groups of patients being examined. It could be that while
researchers tend to view FM as if it was comprised of a homogeneous set of
patients, a more heterogeneous approach should be taken (22). Although many
symptoms are common, FM patients seem to be a group with diverse
characteristics and responses. In order to better understand the syndrome, it
might be profitable to look for commonalities that would divide FM patients into
multiple subgroups under a larger diagnosis.
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